Pfizer Inc. (LON:0Q1N)

London flag London · Delayed Price · Currency is GBP · Price in USD
24.08
-0.23 (-0.93%)
At close: May 1, 2025
Market Cap 103.83B
Revenue (ttm) 48.25B
Net Income (ttm) 6.09B
Shares Out n/a
EPS (ttm) 1.07
PE Ratio 17.05
Forward PE n/a
Dividend 1.33 (5.82%)
Ex-Dividend Date May 9, 2025
Volume 63,181
Average Volume 299,109
Open 24.40
Previous Close 24.30
Day's Range 23.81 - 24.42
52-Week Range 19.48 - 25.24
Beta 0.60
RSI 58.35
Earnings Date Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Q1N
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.